Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 289,940
  • Shares Outstanding, K 65,155
  • Annual Sales, $ 8,200 K
  • Annual Income, $ -158,900 K
  • 60-Month Beta 0.63
  • Price/Sales 35.84
  • Price/Cash Flow N/A
  • Price/Book 27.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.41
  • Number of Estimates 2
  • High Estimate -0.41
  • Low Estimate -0.42
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +36.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.60 +68.21%
on 07/29/19
4.82 -9.44%
on 08/23/19
+1.14 (+35.56%)
since 07/23/19
3-Month
2.60 +68.21%
on 07/29/19
6.92 -36.92%
on 05/24/19
-1.99 (-31.26%)
since 05/23/19
52-Week
2.60 +68.21%
on 07/29/19
14.35 -69.58%
on 09/04/18
-8.84 (-66.93%)
since 08/23/18

Most Recent Stories

More News
Dynavax Technologies Corporation (DVAX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Dynavax Technologies Corporation (DVAX).

DVAX : 4.32 (-2.92%)
Watch for Dynavax Technolo to Potentially Pullback After Gaining 1.02% Yesterday

Dynavax Technolo (NASDAQ:DVAX) traded in a range yesterday that spanned from a low of $3.63 to a high of $4.05. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of...

DVAX : 4.32 (-2.92%)
Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors

-- Bain Capital Life Sciences Managing Director brings extensive capital markets and diverse life sciences industry experience

ALNA : 4.07 (-6.86%)
MRSN : 2.33 (-8.63%)
DVAX : 4.32 (-2.92%)
EDIT : 24.07 (-4.82%)
Watch for Dynavax Technolo to Potentially Pullback After Gaining 9.90% Yesterday

Dynavax Technolo (NASDAQ:DVAX) traded in a range yesterday that spanned from a low of $3.03 to a high of $3.33. Yesterday, the shares gained 9.9%, which took the trading range above the 3-day high of...

DVAX : 4.32 (-2.92%)
Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock

Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, today announced the pricing of an underwritten...

DVAX : 4.32 (-2.92%)
Dynavax Technologies (DVAX) Reports Q2 Loss, Tops Revenue Estimates

Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -4.76% and 4.94%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

DVAX : 4.32 (-2.92%)
Dynavax Technologies: 2Q Earnings Snapshot

BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Wednesday reported a loss of $42.7 million in its second quarter.

DVAX : 4.32 (-2.92%)
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock

Dynavax Technologies Corporation (Nasdaq: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and commercializing novel vaccines, today announced that it intends to offer...

DVAX : 4.32 (-2.92%)
Dynavax Announces Second Quarter 2019 Financial Results

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today reported financial results for the second quarter ended June 30, 2019.

DVAX : 4.32 (-2.92%)
Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7

Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on developing novel vaccines, will report its second quarter 2019 financial results on Wednesday, August...

DVAX : 4.32 (-2.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade DVAX with:

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

2nd Resistance Point 4.82
1st Resistance Point 4.63
Last Price 4.32
1st Support Level 4.35
2nd Support Level 4.26

See More

52-Week High 14.35
Fibonacci 61.8% 9.86
Fibonacci 50% 8.47
Fibonacci 38.2% 7.09
Last Price 4.32
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar